4//SEC Filing
KOVEN ANDREW I 4
Accession 0001415889-22-006749
CIK 0001479419other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:45 PM ET
Size
5.4 KB
Accession
0001415889-22-006749
Insider Transaction Report
Form 4
KOVEN ANDREW I
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-16+50,000→ 50,000 totalExercise: $0.36Exp: 2032-06-15→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 16, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 16, 2023 or (ii) the date of the first annual meeting following June 16, 2022.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001258673
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:45 PM ET
- Size
- 5.4 KB